Le Lézard
Classified in: Health
Subject: SVY

Global Endocrinology Drugs Market 2018-2022


NEW YORK, Sept. 25, 2018 /PRNewswire/ -- About Endocrinology Drugs

Endocrinology is a branch of biology and medicine concerned with the study of the endocrine system. Endocrine disorders include diabetes, thyroid hormone disorders, and sexual dysfunction.

Read the full report: https://www.reportlinker.com/p03793964

Technavio's analysts forecast the Global Endocrinology Drugs Market to grow at a CAGR of 6.48% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the endocrinology drugs market. To calculate the market size, the report considers the revenue generated from the sales of endocrinology drugs.

Technavio's report, endocrinology drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The market is divided into the following segments based on geography:
? Americas
? APAC
? EMEA

Key vendors
? Abbvie
? Merck
? Novo Nordisk
? Pfizer

Market driver
? Increase in patient awareness
? For a full, detailed list, view our report

Market challenge
? Shortage of endocrinologists
? For a full, detailed list, view our report

Market trend
? Use of biosimilars for endocrine disorders
? For a full, detailed list, view our report

Key questions answered in this report
? What will the market size be in 2022 and what will the growth rate be?
? What are the key market trends?
? What is driving this market?
? What are the challenges to market growth?
? Who are the key vendors in this market space?
? What are the market opportunities and threats faced by the key vendors?
? What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Read the full report: https://www.reportlinker.com/p03793964

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: